Latest & greatest articles for pneumonia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pneumonia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pneumonia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pneumonia

41. Antimicrobial drug resistance amongst Escherichia coli, Klebsiella pneumoniae, Streptococcus pneumoniae and Staphylococcus aureus isolates: a systematic review of the worldwide literature

Antimicrobial drug resistance amongst Escherichia coli, Klebsiella pneumoniae, Streptococcus pneumoniae and Staphylococcus aureus isolates: a systematic review of the worldwide literature Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2019 PROSPERO

42. Caregivers' and health care workers' experiences in the management of childhood pneumonia in low- and lower middle-income countries: a qualitative systematic review protocol

Caregivers' and health care workers' experiences in the management of childhood pneumonia in low- and lower middle-income countries: a qualitative systematic review protocol Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

43. Clinical practice guidelines for the management of community-acquired pneumonia: a critical appraisal using the AGREE II instrument

Clinical practice guidelines for the management of community-acquired pneumonia: a critical appraisal using the AGREE II instrument Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

44. Chinese herbal medicine for treating virus pneumonia: a systematic review and meta-analysis

Chinese herbal medicine for treating virus pneumonia: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

45. The clinical outcomes of combination versus monotherapy in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a systematic review and meta-analysis

The clinical outcomes of combination versus monotherapy in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

46. Comparing the clinical outcomes of quinolones versus macrolides in the treatment of legionella pneumonia: a systematic review and meta-analysis

Comparing the clinical outcomes of quinolones versus macrolides in the treatment of legionella pneumonia: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

47. Comparative efficacy and safety of therapeutic options for extensively drug - resistant Klebsiella pneumoniae infections: a systematic review and network meta-analysis

Comparative efficacy and safety of therapeutic options for extensively drug - resistant Klebsiella pneumoniae infections: a systematic review and network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

48. Mortality due to polymyxin resistant klebsiella pneumoniae infections: a systematic review and meta-analysis

Mortality due to polymyxin resistant klebsiella pneumoniae infections: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

49. Vitamin C supplementation for prevention and treatment of pneumonia [Cochrane protocol]

Vitamin C supplementation for prevention and treatment of pneumonia [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

50. The impact of pneumococcal conjugate vaccines on carriage and pneumococcal pneumonia in Africa, 2000-2019: protocol for systematic review

The impact of pneumococcal conjugate vaccines on carriage and pneumococcal pneumonia in Africa, 2000-2019: protocol for systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

51. The impact of Candida spp. airway colonization on clinical outcomes in patients with ventilator-associated pneumonia (VAP): a systematic review and meta-analysis

The impact of Candida spp. airway colonization on clinical outcomes in patients with ventilator-associated pneumonia (VAP): a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

52. The efficacy of adjunctive zinc supplementation in treatment of children with pneumonia in low- and middle-income countries

The efficacy of adjunctive zinc supplementation in treatment of children with pneumonia in low- and middle-income countries Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

53. Risk factors of pneumocystis pneumonia in solid organ transplant recipients

Risk factors of pneumocystis pneumonia in solid organ transplant recipients Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

54. Estimating the effect of pneumococcal conjugate vaccines on childhood pneumonia in sub-Saharan Africa: a systematic review

Estimating the effect of pneumococcal conjugate vaccines on childhood pneumonia in sub-Saharan Africa: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

55. lmmunochromatography for the diagnosis of Mycoplasma pneumoniae infection: a systematic review and meta-analysis

lmmunochromatography for the diagnosis of Mycoplasma pneumoniae infection: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

56. Interventions to prevent aspiration pneumonia in older adults: an updated systematic review

Interventions to prevent aspiration pneumonia in older adults: an updated systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

57. Worldwide prevalence of 30-day readmissions in aged inpatients with pneumonia: a meta-analysis of comparative studies and epidemiological surveys studies

Worldwide prevalence of 30-day readmissions in aged inpatients with pneumonia: a meta-analysis of comparative studies and epidemiological surveys studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

58. Whole lung lavage/bronchoalveolar lavage for exogenous lipoid pneumonia: a systematic review

Whole lung lavage/bronchoalveolar lavage for exogenous lipoid pneumonia: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

59. Pneumonia events associated with PD-1/PD-L1 inhibitors in cancer patients: a number needed to treat analysis of randomized clinical trials

Pneumonia events associated with PD-1/PD-L1 inhibitors in cancer patients: a number needed to treat analysis of randomized clinical trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

60. Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia. (PubMed)

Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia. The Hospital Readmissions Reduction Program (HRRP) has been associated with a reduction in readmission rates for heart failure (HF), acute myocardial infarction (AMI), and pneumonia. It is unclear whether the HRRP has been associated with change in patient mortality.To determine whether the HRRP was associated (...) with a change in patient mortality.Retrospective cohort study of hospitalizations for HF, AMI, and pneumonia among Medicare fee-for-service beneficiaries aged at least 65 years across 4 periods from April 1, 2005, to March 31, 2015. Period 1 and period 2 occurred before the HRRP to establish baseline trends (April 2005-September 2007 and October 2007-March 2010). Period 3 and period 4 were after HRRP announcement (April 2010 to September 2012) and HRRP implementation (October 2012 to March 2015

2018 JAMA